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Key points
 Despite their immense physiological and pathophysiological importance, we know very little
about the biology of dense core vesicle (DCV) trafficking in the intact mammalian brain.
 DCVs are transported at similar average speeds in the anaesthetized and awake mouse brain
compared to neurons in culture, yet maximal speed and pausing fraction of transport were
higher.
 Microtubule plus (+)-end extension imaging visualized microtubular growth at 0.12 μm/s
and revealed that DCVs were transported faster in the anterograde direction.
 DCV transport slowed down upon presynaptic bouton approach, possibly promoting synaptic
localization and cargo release.
 Our work provides a basis to extrapolate DCV transport properties determined in cultured
neurons to the intact mouse brain and reveals novel features such as slowing upon bouton
approach and brain state-dependent trafficking directionality.
Abstract Neuronal dense core vesicles (DCVs) transport many cargo molecules like neuro-
peptides and neurotrophins to their release sites in dendrites or axons. The transport properties
of DCVs in axons of the intact mammalian brain are unknown. We used viral expression of
a DCV cargo reporter (NPY-Venus/Cherry) in the thalamus and two-photon in vivo imaging
to visualize axonal DCV trafficking in thalamocortical projections of anaesthetized and awake
mice. We found an average speed of 1 μm/s, maximal speeds of up to 5 μm/s and a pausing
fraction of 11%. Directionality of transport differed between anaesthetized and awake mice. In
vivo microtubule +-end extension imaging using MACF18-GFP revealed microtubular growth
at 0.12 μm/s and provided positive identification of antero- and retrograde axonal transport.
Consistent with previous reports, anterograde transport was faster (2.1 μm/s) than retrograde
transport (1.4 μm/s). In summary, DCVs are transported with faster maximal speeds and
lower pausing fraction in vivo compared to previous results obtained in vitro. Finally, we found
that DCVs slowed down upon presynaptic bouton approach. We propose that this mechanism
promotes synaptic localization and cargo release.
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Introduction
Neuronal dense core vesicles (DCVs) represent a
diverse group of large secretory granules containing an
electron-dense core as defined by electron microscopy.
DCV cargo molecules differ between neuronal subtypes
and include a variety of signalling molecules like neuro-
peptides, neurotrophic factors (such as BDNF), guidance
cues, extracellular proteases and others. These signalling
molecules are important for a variety of functions
including synaptic plasticity, neurotransmission, neuro-
nal development and survival (Huang & Reichardt, 2001;
Samson et al. 2006; Cohen & Greenberg, 2008; van den
Pol, 2012). Moreover, DCV cargos play important roles in
several diseases such as social anxiety disorders (oxytocin
and vasopressin) (Meyer-Lindenberg et al. 2011)), stress
disorders (NPY) (Reichmann & Holzer, 2015) and
neurodegenerative diseases such as Alzheimer’s disease
(Reichmann & Holzer, 2015). Despite their immense
physiological and pathophysiological importance, we
know very little about the biology of DCV trafficking in
the intact mammalian brain.
DCVs are produced in the Golgi network (Kim et al.
2006) and transported via microtubule-dependent motor
proteins (Zahn et al. 2004; Kwinter et al. 2009; Lo et al.
2011) towards their axonal or dendritic release sites. In
contrast to synaptic vesicles, the content released by DCVs
is not recycled locally, but degraded by membrane- or
circulating metallo-endopeptidases (Rose et al. 2009).
The highly dynamic transport of DCVs (Hartmann et al.
2001; de Wit et al. 2006; van de Bospoort et al. 2012;
Wong et al. 2012; Farina et al. 2015; Gumy et al. 2017)
ensures a reliable supply to often very distant locations in
the axon and dendrites. Previous studies have shown an
anterograde and retrograde cycling of DCVs through the
axon with sporadic pauses in axonal en-passant boutons,
also referred to as varicosities, which was concluded
to represent an activity-dependent capture mechanism
(Shakiryanova et al. 2006; Wong et al. 2012). The function
of this mechanism is probably to enhance availability
of DCVs at synapses to facilitate regulated secretion.
The fusion of DCVs with the plasma membrane mostly
occurs at/near synapses and can be induced with electrical
high-frequency stimulation in vitro (Hartmann et al.
2001; de Wit et al. 2009; van de Bospoort et al. 2012).
To date, it is not known if DCV transport in vivo
is influenced by properties of the surrounding neuro-
pil. Studies addressing DCV trafficking in the intact
mammalian brain are lacking. The dense packaging of
axonal and dendritic compartments within the neuropil
could mechanically affect local trafficking conditions, in
particular when considering that axons can have diameters
of less than 100 nm (Berbel & Innocenti, 1988), about
the size of one DCV. Furthermore, neuro-glial interaction
could affect DCV trafficking. In addition to these factors,
different functional states of the brain such as sleep or
wakefulness may have an impact on the properties of
DCV trafficking and release. On a cellular level, different
patterns of spontaneous and evoked activity in neurons in
the intact brain, known to be more extensive than typically
present in cultured neurons or acute brain slices, could
significantly affect DCV transport properties. Until now,
DCV transport was only studied in neuronal cell culture
and model organisms like D. melanogaster (Wong et al.
2012) and C. elegans (Zahn et al. 2004). Hence, to under-
stand the contribution of aforementioned factors to DCV
trafficking and to extrapolate published data obtained in
reduced cell culture or brain slice preparations to living
and behaving mammals, DCVs need to be imaged within
the intact brain.
We established an in vivo DCV imaging approach using
chronically implanted cranial windows and two-photon
microscopy in anaesthetized and awake mice to describe
the basic DCV transport characteristics in thalamocortical
axons ramifying in the molecular layer of the primary
motor cortex. We show that DCVs travel through
thalamocortical axons in vivo with an average speed of
1 μm/s and maximal speeds of up to 5 μm/s with
infrequent pauses. Furthermore, we show that DCVs
preferentially slow down near presynaptic en-passant
boutons. We propose this mechanism helps to promote




This study was carried out in accordance with the
European Communities Council Directive (86/609/EEC)
to minimize animal pain or discomfort. All experiments
were conducted following the German animal welfare
guidelines specified in the TierSchG. The local animal
care and use committee (Regierungspräsidium Karlsruhe
of the state Baden-Württemberg) gave approval for the
study under the number G167/15. The authors declare
that the reported experiments comply with The Journal of
Physiology’s ethical principles and its checklist on animal
experimentation. Male C57Bl/6N mice were acquired
from Charles River Laboratories (Sulzfeld, Germany) at
an age of 8 weeks. The mice were kept at a 12—12 h
C© 2018 The Authors. The Journal of Physiology C© 2018 The Physiological Society
J Physiol 596.16 Imaging secretory vesicle trafficking in vivo 3761
dark–light cycle synchronized with the local day–night
cycle. Water and food were available ad libitum, except
for the imaging sessions. Mice were generally housed in
ventilated racks with up to 3 animals per cage, but were
separated after surgery to minimize the risk of injury.
After completion of the experiments, mice were killed with
an overdose of Narcoren (Merial GmbH, Hallbergmoos,
Germany; 500 mg kg−1 bodyweight I.P.).
Immunohistochemistry
For immunohistochemistry, mice were deeply anaes-
thesised with Narcoren (500 mg kg−1 bodyweight I.P.)
and transcardially perfused with 4% paraformaldehyde
(PFA) in phosphate-buffered saline (PBS). The brains
were post fixed overnight in 4% PFA and then sliced into
70 μm thick sections and stored in PBS. For increased
permeabilization, the slices on which the chromogranin
stains were performed on, were treated with 1% sodium
dodecyl sulfate (SDS) in PBS for 5 min before the antibody
stainings. For antibody staining the slices were incubated
for 1 h in PBS containing 5% normal goat serum (NGS),
1% bovine serum albumin (BSA), 1% cold fish gelatin
and 0.5% Triton X-100. Incubations with primary anti-
bodies were done overnight at 4°C. The secondary anti-
bodies were incubated for 1–2 h at room temperature.
Primary antibodies were: Bassoon (Enzo Life Sciences,
SAP7F407; 1:1000, RRID:AB 2313990), chromogranin A
(Synaptic Systems, Göttingen, Germany, 259003; 1:500,
RRID:AB 2619972), chromogranin B (Synaptic Systems,
259103, 1:500, RRID:AB 2619973), early endosomal
antigene 1 (Eea1) (Abcam, Cambridge, UK; ab2900;
1:200, RRID:AB 2262056), Homer1 (Synaptic Systems,
160003; 1:200, RRID:AB 887730), Lamp-2 (Santa Cruz
Biotechnology, Heidelberg, Germany, sc-18822; 1:200,
RRID: AB 626858, kind gift from Ralph Nawrotzki),
LC-3 (Medical & Biological Laboratories, Nagoya, Japan,
M-152-3; 1:100; RRID:AB 1279144, kind gift from Ralph
Nawrotzki), Piccolo (Synaptic Systems, 142104; 1:1000,
RRID:AB 2619831), Rab5 (Abcam, ab18211; 1:200, RRID:
AB 470264, kind gift from Ralph Nawrotzki). Alexa Fluor
antibodies from Invitrogen were used as secondary anti-
bodies in a dilution of 1:500. The slices were mounted
in SlowFade Gold (Life Technologies) and imaged on a
Leica SP8 inverted confocal microscope with a 63× oil
immersion objective (NA = 1.4) and maximal resolution
in x, y and z planes (0.08 μm × 0.08 μm × 0.3 μm).
Genetic labelling of DCVs and thalamo-cortical axons
using viral gene transfer
DCVs were labelled in vivo in mice by viral expression
of a fusion protein consisting of Neuropeptide Y (NPY)
and the yellow fluorescent protein Venus (NPY-Venus)
(Fig. 1A and B) or the red fluorescent protein mCherry
(van de Bospoort et al. 2012; Farina et al. 2015),
driven by the synapsin promoter. Axonal projections
were labelled by expressing mCherry under the control
of the CAG (chicken-beta-actin) promoter in thalamic
projection neurons. Microtubule plus (+)-ends were
marked by expression of green fluorescent protein (GFP)
fused to the first 18 N-terminal amino acid residues
of the microtubule +-end marking protein MACF43
fused to the two-stranded leucine zipper coiled-coil
sequence corresponding to GCN4-p1 under control of the
synapsin promoter as described elsewhere (Yau et al. 2016)
(GFP-GCN4-MACF18). Recombinant adeno-associated
virus (AAV) particles of the chimeric 1/2 serotype were
produced with the plasmids described above (Schwenger
& Kuner, 2010).
Craniectomy, stereotaxic injection and chronic
window implantation
For viral injection (Wimmer et al. 2004) and craniectomy
(protocol adapted from Holtmaat et al. 2009), mice were
anaesthetized with an intraperitoneal (I.P.) injection of a
mixture of 0.48 μl fentanyl (1 mg/ml; Janssen), 1.91 μl
midazolam (5 mg/ml; Hameln) and 0.74 μl medetomidin
(1 mg/ml; Pfizer) per gram body weight each and placed
in a stereotaxic head holder (Kopf). Depth of anaesthesia
was monitored by checking for vibrissal movements,
breathing frequency and pain reflexes. Before cutting
of the skin, xylocaine solution (1%; Astra Zeneca) was
injected subcutaneously. A small hole in the skull was
made with a dental drill over the injection site. Then,
1 μl of a 1:1 mixture of the NPY-Venus and mCherry
or a mixture of MACF-GFP and NPY-mCherry AAV
particles was slowly injected into the right medio-dorsal
thalamus (Coordinates from bregma: x = 1.13, y = -0.82,
z = -3.28). Afterwards a circular craniectomy (approx.
6 mm, centre positioned 1 mm right of bregma) was
drawn with a dental drill. The dura was carefully removed.
A sterile round no. 0 coverslip with a diameter of
6 mm (cranial window) and a custom-made round
plastic holder surrounding it for head fixation were
cemented on the skull with dental acrylic (Hager &
Werken).
After surgery, mice received I.P. a mixture of
1.86 μl naloxon (0.4 mg/ml; Inresa), 0.31 μl flumazenil
(0.1 mg/ml; Fresenius Kabi), 0.31 μl antipamezole
(5 mg/ml; Pfizer) in 3.72 μl saline (0.9%; Braun) each
per gram body weight to antagonize the anaesthesia.
Mice were given carprofen (Rimadyl, 5 mg/kg; Pfizer)
in saline before surgery and during the following days
in intervals of 12 h for 3 days. Mice were single housed
after surgery and typically imaged at least 21 days after
C© 2018 The Authors. The Journal of Physiology C© 2018 The Physiological Society
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the surgery. This waiting period is essential for the glial
reaction below the window to subside (Holtmaat et al.
2009).
In vivo two-photon imaging
Two-photon imaging of small structures like DCVs
provides a challenge that is illustrated in Fig. 1C and D.
A DCV positioned anywhere within the focal volume will
result in a similar signal. Single labelled DCVs compete
with background autofluorescence signals (blue filled
circles, Fig. 1C). To be detectable, the fluorescence signal
arising from the DCV will have to exceed the number of
autofluorescence signals present in the background. DCVs
located outside the focal volume will not be detected.









Figure 1. Experimental design
A, NPY-Venus shown as an approximated molecular model to clarify the relative size of the components of the
fusion protein. B, EM image of a DCV with an arbitrary number of NPY-Venus molecules (green) to illustrate
the DCV labelling strategy. Scale bar, 20 nm. C, the red oval shape represents the illuminated focal volume of
two photon excitation (approximated from the point-spread function). Lines illustrate an axon positioned within
the focal volume. Blue dots denote background fluorescence. D, situation illustrating the presence of two axons
and multiple DCV within a single focal volume (see Methods section for further discussion). E, injection of AAVs
encoding NPY-Venus and mCherry into the area of the right medio-dorsal thalamus (1). Position of objective
for imaging (2). Note the orientation of superficial axons in parallel to the brain surface. F, chronic window
implantation after stereotaxic delivery. G, setup for awake imaging. The mouse is fixed via the crown, but able to
move on a freely rotatable disc. H, mosaic scan of thalamic injection site and axonal projection emanating from it
(wide-field epifluorescence imaging of an 80 μm thick section; scale bar, 1 mm). Yellow rectangle depicts region
of interest imaged in primary motor cortex, 30–80 μm below the pial surface. I, example image of a single frame
used for in vivo two-photon time-lapse imaging 40 μm below the pial surface. mCherry-labelled axons (red) and
NPY-Venus-labelled DCVs (green), DCVs in labelled axons appear yellow. Scale bar, 50 μm. J, magnified view of
region marked in I. Scale bar, 10 μm.
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a single focal volume, making it impossible to assign the
total fluorescence recorded to the individual axons. Hence,
imaging requires a low density of axons within the imaging
volume. Multiple DCVs placed within the same axon and
focal volume will be detected as a single, yet brighter,
fluorescence spot. If these DCVs move together, it will be
difficult to precisely identify the number of DCVs within
that cluster.
Two-photon imaging (Denk et al. 1994) was performed
with a TriM Scope II microscope (LaVision BioTec GmbH)
equipped with a pulsed Ti:Sapphire laser (Chameleon;
Coherent). 960 nm was used for simultaneous excitation
of both Venus and mCherry. For the experiments with
MACF-GFP and NPY-mCherry, a wavelength of 995 nm
was used. Imaging was performed with a 25× water
immersion objective (Nikon MRD77225, NA = 1.1) and
appropriate filter sets (Venus: 535/70 nm and mCherry:
650/100; Chroma). Fluorescence emission was detected
with low-noise high-sensitivity photomultiplier tubes
(PMTs, H7422-40-LV 5M; Hamamatsu). For the imaging
sessions, anaesthesia was induced with 6% isoflurane
(Baxter) in oxygen and maintained at 0.8–1%. Depth
of anaesthesia was monitored by checking for vibrissal
movements, breathing frequency and pain reflexes. The
anaesthetized mouse was head fixed by clamping the
plastic holder cemented to the skull. For awake imaging,
the mouse was fixed over a rotatable disc treadmill
(Fig. 1G) under isoflurane anaesthesia and the isoflurane
was shut off after fixing. The awake imaging was started at
least 5 min after the end of isoflurane anaesthesia. Frames
were typically taken from an area of 196.6 × 196.6 μm at
1024 × 1024 pixel resolution with a frame rate of 1.06 Hz
for 10 min per dataset using the galvanometric scanner of
the TriM Scope II. Anaesthetized imaging sessions lasted
no longer than 1 h and awake imaging sessions no longer
than 20 min.
Processing and analysis of imaging data
The acquired movies were registered for image movement
in the x–y plane with the Fiji (RRID:SCR 002285)
Plugin ‘Descriptor based series registration’ (Preibisch
et al. 2010). Generally, during anaesthetized imaging
sessions, resulting displacement in x–y was less than
10 μm. The resulting stacks were deconvolved using
the Richardson-Lucy algorithm implemented in Matlab
(RRID:SCR 001622) and a theoretical PSF, background
subtracted and median-filtered. To only analyse moving
particles, the average projection of the registered time lapse
was subtracted from every image. For the semi-automated
tracking of the DCV puncta the Fiji Plugin ‘Trackmate’
(Tinevez et al. 2016) was used. The automatically tracked
parts were manually reviewed. The tracks were stopped
when the puncta were not visible for more than two
images. The resulting coordinates in x, y and t (time)
were analysed with custom written Matlab scripts. Only
tracks exceeding 10 consecutive images were analysed. The
maximal speed per track was defined as highest mean of
the speed out of 4 consecutive track points. The mean
speed was averaged over all computed mean speeds of
all tracks. The unidirectionality factor was defined as the
fraction of the puncta moving in the direction of the main
movement vector as defined by the first and last track
point. To calculate this, each movement episode of all
puncta present in the axon was classified to be forward or
reverse with the unidirectionality factor defined as number
of forward movements/number of reverse movements.
Hence, an unidirectionality factor of 1 corresponds to
a consistent movement of puncta in one direction while
values below 1 indicate that some of the puncta also moved
in the opposite direction. A value of 0.5 would indicate that
the same number of puncta moved forward and reverse,
suggesting no preferential movement direction.
The MACF18-GFP comets were analysed using
kymographs. Lines fitted over tracks in the kymographs
were analysed with an ImageJ macro written by Alessandro
Moro which uses a kymograph plugin (Bioimaging and
Optics Platform) (Seitz & Surrey, 2006).
Statistics
All statistics were calculated using Prism (GraphPad,
RRID:SCR 002798). Normality distribution of the data
was tested using Kolmogorov-Smirnov, D’Agos-
tino-Pearson and Shapiro-Wilk tests. Most analysed
data did not show a gaussian distribution. Hence,
distributions of the datasets were compared with
non-parametric two-sided Mann-Whitney tests.
A P value below 0.05 was considered statistically
significant. Means reported in the text are given with
the standard error of the mean (SEM) unless noted
otherwise.
Results
To image DCVs in vivo, vesicles and axons were
fluorescently labelled with NPY-Venus (Fig. 1A–D; see
Methods for detailed discussion), a previously optimized
DCV reporter (de Wit et al. 2009), and mCherry,
using viral gene transfer into the right medio-dorsal
thalamus (Fig. 1E). Thalamo-cortical projection neurons
were chosen as a model system, because their axons
branch intracortically in the superficial layer 1 and run
parallel to the surface of the brain, thereby providing
ideal conditions for DCV imaging. Chronically implanted
cranial windows (Fig. 1F) permitted in vivo two photon
microscopy in anaesthetized or awake mice (Fig. 1G)
C© 2018 The Authors. The Journal of Physiology C© 2018 The Physiological Society
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(Holtmaat et al. 2009). Three weeks after viral injection
and chronic window insertion, imaging commenced using
960 nm excitation for simultaneous visualization of axons
and labelled DCVs. The thalamic injection site and
mCherry-labelled axonal projections reaching the surface
of the brain are schematically indicated in Fig. 1H, with
the yellow rectangle indicating an area situated 30–80 μm
below the pial surface, from which time-lapse data were
acquired. An example of an in vivo two-photon imaging
experiment is shown in Fig. 1I, illustrating that labelling
of thalamocortical axons with mCherry allowed detection
of axons positioned within a single imaging frame, an
important precondition to monitor moving DCVs (yellow
dots in Fig. 1J, Supporting Movie S1). The signal of
analysed vesicles shows a mean signal to noise ratio
between 2:1 and 4:1 as measured by the mean fluorescence
of the vesicle divided by the background, thus providing
reliable imaging conditions.
The time-lapse movies regularly showed large static
fluorescent clusters that did not overlap with the mCherry
labelled axons. These might represent either cellular auto-
fluorescent debris or released fluorescent cargo of the
DCVs that has been taken up by cells, possibly astrocytes
or microglia. Co-staining for an astrocytic marker and a
marker of early endosomes demonstrated an overlap of
a portion of this fluorescent cargo and astrocytic early
endosomes (data not shown).
To control for the correct packaging of the DCV
cargo reporter, NPY-Venus, into DCVs under in vivo
conditions, we immunostained fixed brain slices with
the endogenous DCV markers chromogranin A and B
(Chr-A, Chr-B). NPY-Venus-labelled DCVs were detected
in mCherry-labelled axons and overlapped with Chr-A
and Chr-B stainings (Fig. 2A and B). We found no over-
lapping fluorescent signals of NPY-Venus puncta with
other cellular structures such as endosomes, lysosomes,
autophagosomes or presynaptic proteins (Fig. 2C–H).
To exclude that expression of the DCV cargo reporter
induced the formation of DCVs in cells that may not
a priori produce DCVs, we labelled thalamic axons
with mCherry and immunostained for Chr-A (data
not shown). This experiment demonstrates the presence
of DCVs in thalamocortical axons independent of the
NPY-Venus expression. In summary, these results suggest
that the DCV cargo reporter NPY-Venus correctly labelled
DCVs in neurons that endogenously produce DCVs,
consistent with previous observations made in cultured
neurons (Taraska et al. 2003; Farina et al. 2015).
Visualizing DCV movement in axonal projections in
vivo
DCV trafficking in thalamocortical axons was monitored
by time-lapse imaging of DCV reporter fluorescence
and axonal fluorescence in single focal planes at 1 Hz.
Individual DCV puncta can be assigned to the axons
they are travelling in (Fig. 3A) and subsequently tracked
(Fig. 3B). Small fluctuations in the apparent size of the
puncta along the trajectory may arise from axons not
running perfectly in parallel to the imaging plane, so that
different amounts of fluorescent proteins in the vesicles
are excited (see Fig. 1C and D). Alternatively, changes in
the z focus position in response to slight movements of the
tissue may account for fluctuations in apparent size of the
puncta. The average length of axonal segments analysed
was 30 ± 10 μm and time-lapse movies lasted for typically
10 min. At t = 2 s, the DCVs marked yellow and blue in
Fig. 3B appear to travel within the same diffraction-limited
focal volume. Such co-travelling events were encountered
only rarely (on average less than once in each kymograph
of 51 axon stretches analysed). During the time period
from 2 s to 14 s, the puncta labelled green and orange travel
with different speeds (1.6 μm/s; 0.6 μm/s) in the same
direction. This is further illustrated in the kymograph
(Fig. 3C). Hence, tracing of labelled DCVs can be achieved
with the approach introduced here, including quantitative
analyses.
Quantification of DCV trafficking characteristics in
vivo
Following the experimental scheme shown in Fig. 1,
a total of 279 vesicles in eight mice were tracked
semi-automatically. The average speed of moving DCV
puncta in vivo in anaesthetized mice was 1.03 ± 0.03 μm/s
(Fig. 4A and J). This is in agreement with previous
observations in cultured mammalian neurons and with
in vivo imaging performed in D. melanogaster, ranging
from speeds of 0.75 μm/s to 1.25 μm/s for axonal DCV
transport (see coloured points in Fig. 4A) (de Wit et al.
2006; Kwinter et al. 2009; Bittins et al. 2010).
The maximum speed per track was defined as the
highest average speed within 4 consecutive track points
of each track. The average maximum speed of the tracked
vesicles was 2.06 ± 0.05 μm/s (Fig. 4B), but we regularly
observed speeds of up to 5 μm/s (in vitro data: 2.6 μm/s
to 3.75 μm/s; de Wit et al. 2006; Bittins et al. 2010).
DCV puncta often slowed down and stopped, but
started moving again at a later time point (pausing). The
pausing time was defined as the percentage of time that a
punctum moved slower than 0.2 μm/s. This corresponds
roughly to a displacement of one pixel per image. The over-
all pausing time of the tracked vesicles was 10.7 ± 0.7%
(Fig. 4C). This is lower than the 22% pausing fraction
reported in cell culture (de Wit et al. 2006).
It was not possible to determine whether DCV puncta
moved in the anterograde or retrograde direction within
the axon, because the position of the soma could not be
C© 2018 The Authors. The Journal of Physiology C© 2018 The Physiological Society
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determined in situ. To analyse if vesicles moved back and
forth, or if they followed a preferred movement vector,
the directionality factor for the overall movement of a
vesicle was calculated. This ‘unidirectionality factor’ was
defined as the fraction of time the vesicle moved along its
overall directional vector defined by the first and last point
of the track. The mean unidirectionality factor of all 279
analysed tracks is 0.86 ± 0.01 (Fig. 4D). This corresponds
to an overall consistent unidirectional movement of the
puncta. The remaining 14% of movements were in the
opposite direction to the main movement vector.
To compare the amount of bidirectional and
unidirectional movement in individual axons, only axons
with more than 5 tracked puncta were investigated to avoid
a possible bias towards unidirectional movement. In total,
25 axons were analysed. The frequency distribution of the
directionality in these axons shows that in approximately














































Signal in axon AB + NPY + outline
Figure 2. Verification of DCV identity
A–H, average intensity projections of 5
consecutive confocal image planes of
immunostained cortical tissue sections
with NPY-Venus-labelled DCVs (green)
and mCherry-labelled axons (blue).
Colocalization of the respective antibody
with DCVs within labelled axons is shown
in the fourth column (Signal in axon), all
signals outside of labelled axons omitted.
The fifth column shows the respective
antibody staining and labelled DCVs, with
labelled axons outlined
(AB + NPY + outline). A and B, antibody
stainings against DCV markers
chromogranin A and chromogranin B.
C–F, antibody stainings against mobile
compartments: endosomes (Rab5,
Ras-related protein 5a; Eea1, early
endosome antigen 1), lysosomes (Lamp2,
lysosome-associated membrane protein
2), autophagosomes (Lc3,
microtuble-associated protein light chain
3). G and H, antibody stainings against
presynaptic active zone proteins: Bassoon,
Piccolo. Scale bars, 2 μm.
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Figure 3. Time-lapse images and kymograph of moving DCVs
in a single axon
A, single two-photon image frame showing an axon labelled with
mCherry (red) and the DCV cargo reporter NPY-Venus (green). Scale
bar, 5 μm. B, time-lapse images of the green channel in panel A.
DCVs labelled blue and yellow at t = 0s travel together (green) in
subsequent frames. C, kymograph of time-lapse in B.
Bidirectional movement was observed in approximately
60% of the axons.
To test possible confounding effects on the trafficking
characteristics due to different expression time and thus
different amounts of DCV cargo reporter expressed, two
mice were imaged twice, at 2–3 weeks and 8–9 weeks after
viral injection (data not shown). No significant differences
in the transport speeds and other trafficking characteristics













































































































































Figure 4. DCV movement dynamics resemble previous in vitro
studies
A–D, box plots of 279 tracked puncta taken from 8 anaesthetized
mice. Box plots show the median and the 25 to 75 percentile, the
whiskers show the 2.5 to 97.5 percentiles. Individual points above or
below the whiskers are outliers. Coloured points represent previous
reported data from in vitro studies. Magenta dots, de Wit et al. 2006
(experiments performed at 32°C); green dots, Bittins et al. 2010;
yellow dots, Kwinter et al. 2009 (experiments performed at 37°C). B,
maximal speed averaged over 4 consecutive track points. C, pausing
time as the percentage of images in which puncta moved with a
speed below 0.2 μm/s. D, directionality of all vesicles. E–H, puncta
tracked in awake mice (n = 46 puncta, 3 mice). No significant
differences (Mann-Whitney test) were found for mean speed
(P = 0.12), maximal speed (P = 0.28), and fraction paused
(P = 0.22), while the directionality differed highly significantly
(P = 0.0001). I, distribution of directionality of transport in axons
with n > 4 tracked vesicles. J, frequency distributions of mean
speeds in awake (black bars) and anaesthetized (grey bars) mice.
points, suggesting that the amount of reporter expressed
did not affect the trafficking properties of DCVs.
In summary, the basic DCV trafficking properties
were similar in the anaesthetized intact brain in
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comparison to a large set of trafficking data pre-
viously described in neuronal cell cultures. However, in
vivo, the peak speed was higher and the pausing time
lower.
Comparison of DCV trafficking in anaesthetized and
awake mice
To control for potential influence of anaesthesia, and
thus brain activity levels in general, on DCV transport,
three mice were imaged in the awake state. Minor axial
movements exceeding 1–2 μm remove the axon stretch
of interest from the imaging plane (see Fig. 1C and D).
Therefore, the base plate of the window was firmly fixed,
both on the skull and in the holder, while placing the
mouse on a rotatable disk (Fig. 1G). The axial focal
plane remained stable, except when the mice started to
run. These episodes were excluded from further analysis.
Forty-six tracks in awake and resting mice were analysed
and trafficking characteristics from these tracks were
compared to all tracks recorded from anaesthetized mice.
The mean speed of DCV puncta was 1.17 ± 0.1 μm/s
in the awake state and did not differ from the mean
speed of 1.03 ± 0.03 μm/s in anaesthetized mice (Fig. 4E,
Supporting Movie S2). This is further illustrated by
the large overlap of the frequency histograms of both
distributions (Fig. 4J). The maximal speed and pausing
time did not differ significantly between anaesthetized and
awake mice (Fig. 4F and G).
The only feature in DCV trafficking that was
significantly different in the awake compared to
anaesthetized mice was the lower directionality factor of
0.79 ± 0.03 in awake animals compared to 0.9 ± 0.01
(Mann-Whitney test, P=0.0002) in anaesthetized animals
(Fig. 4H). This could potentially be explained by inter-
fering movement of the animal that could not be corrected
for during recordings. However, intrinsic differences
caused by the activity state of the brain may also affect DCV
movement directionality, leading to less straightforward
tracks with more pausing and reversing of the movement
direction.
Axonal microtubule dynamics in vivo
To differentiate between anterograde and retrograde
DCV trafficking in vivo, we co-expressed NPY-mCherry
and MACF18-GFP, a minimal fragment of the
microtubule-actin cross-linking factor 2 that gets
selectively incorporated at the microtubule +-end (Yau
et al. 2016). This allowed us not only to determine axonal
orientation for trafficking analysis but also to characterize
axonal microtubule growth dynamics. MACF18-GFP
fluorescence accumulated at the growing microtubule
plus ends are referred to as comets (Fig. 5, Supporting
Movie S3). As overexpression of MT-plus end binding
proteins can lead to the binding to all microtubules
and not only the plus ends (Komarova et al. 2005),
we analysed these mice exclusively after 3–4 weeks of
expression time, where punctate fluorescent and only faint
cytoplasmic signals could be observed in axons. Analysis
of the kymographs of MACF18-GFP comets allowed us
to quantify movement speeds of axonal microtubules in
vivo; 155 comets in 17 axons of four mice were analysed.
We found a mean speed of axonal microtubule poly-
merization in vivo of 0.12 ± 0.01 μm/s (Fig. 5D). This is
in agreement with in vivo findings in spinal cord axons
of 0.147 μm/s (Kleele et al. 2014). The average run
length of single comets was 10.02 ± 0.59 μm (Fig. 5E).
To compare the number of comets per axon stretch
length and time to previously reported numbers, we
calculated the number of comets per micrometer (μm) per
minute (Fig. 5F). With 0.4 comets/min/20 μm (0.02
comets/min/μm) we observed fewer comets than the pre-
viously reported number of 1.8 comets/min/20 μm
(Yau et al. 2016) in dendrites. We found a density of
0.028 ± 0.0002 comets/μm which is in the range of the
data reported by Kleele et al. (2014) in spinal cord axons
(0.033 ± 0.002 comets/μm).
Anterograde versus retrograde DCV trafficking
Assessing the run direction of MACF18-GFP puncta
allowed us to define the directionality of DCV
movement within the same axon as anterograde or
retrograde with respect to the soma. The unidirectional
movement of multiple microtubule comets (green)
within a single axon stretch define the orientation
of this axon: anterograde corresponds to movement
from left to right in the kymograph (Fig. 6A).
The movements of multiple DCVs in the same
axonal stretch (red) reveal their dynamic bidirectional
transport.
In the axons the mean speed of DCV transport in the
anterograde direction was 2.14 ± 0.12 μm/s (n = 78)
and in retrograde direction 1.4 ± 0.08 μm/s (n = 67;
Fig. 6B). This analysis showed a significant difference
in transport speed (Mann-Whitney test, P < 0.0001).
Additionally, we compared mean speeds of anterograde
and retrograde transport within axons (with n > 2 vesicles
in each direction). In almost all axons, the anterograde
vesicles were faster than the retrograde vesicles (Fig. 6F).
The maximum speed, pausing time and unidirectionality
factor showed significant differences in the antero- and
retrograde trafficking directions (Fig. 6C–E). Thus, in
vivo imaging revealed a difference in anterograde and
retrograde trafficking speed comparable to that previously
published in cultured neurons (de Wit et al. 2006) and
invertebrates (Zahn et al. 2004; Barkus et al. 2008).
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DCV trafficking is different near axonal boutons in
vivo
While analysing the tracking data, we noticed that
some of the axons showed different trafficking features
at sites that resembled en-passant boutons, visible as
ellipsoid structures with a diameter of 2–4 μm (Fig. 7A,
red). To confirm that these structures correspond to
axonal boutons, we performed immunostainings for
the pre- and postsynaptic markers synaptophysin and
Homer1, respectively. NPY-Venus puncta overlapped
with synaptophysin-positive puncta within ellipsoid
structures of the axon (Fig. 7B) and were associated with
Homer1-positive puncta nearby (Fig. 7C), indicating that
the ellipsoid structures of typical size and shape represent
presynaptic boutons.
Each of the boutons shown in Fig. 7A contains DCV
puncta that turned out to be immobile or mobile (Fig. 7D,
orange versus red circles). Upon passing the bouton,
mobile puncta slow down near the boutons (red, see
also trajectory in kymograph, Fig. 7E). For the sub-
sequent analysis, 57 tracks of axons with visible boutons
from three mice were compared to tracks in axons
lacking boutons. The average speed of DCV puncta was
significantly lower in the axons containing boutons with a
difference of 0.3 μm/s (Fig. 7F; bouton: 0.78 ± 0.11 μm/s;
non-bouton: 1.10 ± 0.03 μm/s; MW: P < 0.0001).
The maximal speed was significantly lower too, with a
difference of 0.3 μm/s (Fig. 7G; bouton: 1.81 ± 0.16 μm/s;
non-bouton: 2.16 ± 0.05 μm/s; MW: P < 0.0001). The
pausing time of the vesicles was different, with a higher
fraction of pausing vesicles in/around boutons (Fig. 7H;
bouton: 20.43 ± 2.14%; non-bouton: 8.50 ± 0.61%; MW:
P < 0.0001). Finally, changes in movement directionality
were increased in axons containing boutons (Fig. 7I,
0.79 ± 0.02; non-bouton: 0.90 ± 0.01; MW: P < 0.0001).
To investigate further at which distance from the bouton
center the reduction in speed occurred, all bouton centre
points were marked manually. Mean speeds of tracks
outside a certain distance from the centre were analysed
covering a range of 1 to 10 μm (Fig. 7J). A steady decrease
in mean speed from  0.9 μm/s to  0.5 μm/s occurred
within a distance of 10 μm towards the bouton centre.
We conclude that a lower mean speed of vesicles within
and near boutons leads to longer residence of trafficking
DCVs in presynaptic boutons, facilitating the recruitment
of DCVs for secretion in synaptic boutons.
Discussion
We characterized DCV trafficking dynamics in anaesthe-
tized and awake mice in axons of thalamo-cortical
projection neurons. Our experimental protocol allows























































Figure 5. Axonal microtubule dynamics in vivo
A, maximum intensity projection of time-lapse of MACF18-GFP
positive, manually segmented axonal stretch. Scale bar, 5 μm. B,
time-lapse of microtubule +-end growth. Three comets are marked
with coloured circles. C, kymograph of time-lapse shown in B. D–F,
box plots of mean speed, run length and number of comets per
minute per micrometer (μm).
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imaging of fluorescently labelled neuronal DCVs through
chronic cranial windows in mice, transferring basic cell
biology from the culture dish to the more complex and
realistic environment of higher order systems. While many
axonal DCV trafficking properties previously described in
vitro are similar to those revealed here in vivo, we found
a higher peak transport speed, a lower fraction of pausing
DCVs and a slow-down of DCV trafficking upon approach
to axonal boutons. The latter is consistent with a pre-
ferential capture and release of DCVs at presynaptic sites
in the anaesthetized and awake mouse brain.
NPY-Venus-labelled punctate structures showed the
trafficking features of DCVs and were confirmed as
such using staining for chromogranin A/B (Fig. 2A
and B). Furthermore, NPY-Venus signals did not over-
lap with other (mobile) organelles such as endosomes,
lysosomes or autophagosomes, or presynaptic proteins
(Fig. 2C–H). Together, these observations strongly indicate
that NPY-Venus-labelled structures represent DCVs.
The NPY-Venus puncta travelling through axons had
different sizes and fluorescence intensities, suggesting
that puncta may consist of either single or multiple
DCVs (Figs 1J, 3 and 7), consistent with published
in vitro data (van de Bospoort et al. 2012). It has
been argued that thalamocortical and pyramidal cortical
neurons lack DCVs altogether (Torrealba & Carrasco,
2004), although thalamic projection neurons have not
been systematically investigated for DCVs. By selectively
labelling thalamic projection neurons with mCherry and
performing stainings of the endogenous DCV marker
chromogranin A, we could demonstrate that DCVs
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Figure 6. Anterograde versus retrograde trafficking of DCVs in vivo
A, left, kymograph covering 5 min of an axon stretch with green puncta depicting MACF18-GFP comets and
red puncta showing NPY-mCherry in DCVs. A, right, cartoon illustration showing only mobile puncta to facilitate
interpretation of the kymograph. Note that all green puncta move at slow speed in one direction (left to right in the
kymograph), thereby defining anterograde transport. Red puncta move at higher speeds in both directions. B–E,
comparison of 78 tracked vesicles in anterograde and 67 tracked vesicles in retrograde direction in 3 different mice.
MW test showed significant difference in mean and maximal speed as well as in pausing time and unidirectionality
factor (P values: < 0.0001, 0.0002, 0.0021, < 0.0001) F, comparison of mean speeds within axons showing more
than 2 vesicles in each direction.
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expression did not artificially induce DCV biogenesis
and, therefore, our study reports physiologically relevant
processes. In addition to axonal fluorescent clusters, we
also regularly found larger fluorescent clusters outside
the axons. These clusters may reflect autofluorescent
cellular debris near the pial surface, stable deposits of
secreted DCV cargo or endocytosed fluorescent proteins
within scavenger cells such as astrocytes or micro-
glia, or in neurons. Such accumulations of DCV cargo
after their release is a well-known phenomenon in
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Figure 7. Reduced DCV trafficking speed at en-passant boutons
A, single two-photon frame showing a mCherry-labelled axon containing NPY-Venus puncta, white asterisks
indicate en-passant boutons. B and C, three colour labelling as indicated next to the panels. Average intensity
projections of 5 consecutive confocal image planes. Scale bar, 2 μm. D, time-lapse images of NPY-Venus puncta.
Stationary DCV (orange circle) and moving/pausing DCV (red circle). Scale bar, 5 μm. E, kymograph of time-lapse in
D. F–I, comparison of 245 tracks from axons lacking boutons with 57 tracks from axons having visible boutons. The
groups are significantly different in all analysed trafficking characteristics (Mann-Whitney test; P values < 0.0001).
J, mean speeds of tracks in relation to their distance to the bouton.
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The DCV velocities and directionality of their transport
determined here generally correspond well with previously
reported data from in vitro experiments and studies in
other model systems (Zahn et al. 2004; de Wit et al. 2006;
Barkus et al. 2008; Kwinter et al. 2009; Bittins et al. 2010).
The higher peak speed and shorter pausing time observed
in vivo might be due to different temperatures in cell
culture experiments or the fact that axonal microtubule
orientation is different in mammals and invertebrates
(del Castillo et al. 2015). Furthermore, neuronal activity
patterns are probably different in vitro and in vivo and lead
to a different amount of arrest, as DCV arrest is induced
by activity (de Wit et al. 2006). Finally, we observed a wide
range of DCV trafficking patterns: Faster vesicles passing
slower ones in the same direction, vesicles first travelling
alone, then together to finally be separated again, vesicles
passing each other in different directions, most vesicles
slowing down mid-travel to pause for a short time and
others travelling with a constant speed over the whole
tracked distance. The frequent changes in movement speed
and also directionality may be due to different motor
proteins of the kinesin family bound to the same vesicle,
possibly in combination with a dynein motor, thereby
defining the speed of the vesicles as a product of the
individual speeds of the motors involved (Gumy et al.
2017). Another reason for the directionality changes might
be switching between different motor proteins. These
diverse in vivo trafficking patterns resemble patterns pre-
viously observed in vitro (de Wit et al. 2006). In conclusion,
the general properties of DCV trafficking in the intact
mouse brain are in agreement with previous findings in
neuronal primary cell culture and invertebrates. This may
be attributed to the high conservation of motor proteins
that are responsible for DCV transport in all investigated
model systems (Zahn et al. 2004; Barkus et al. 2008).
Coexpression of the microtubule marker MACF18-GFP
with the DCV marker NPY-mCherry allowed us to
distinguish between anterogradely and retrogradely
moving DCVs. The mean speed of all anterogradely
travelling DCVs was 2.14 μm/s, approximately 50% faster
than vesicles moving retrogradely, at 1.4 μm/s. This is
in accordance with findings from cultured hippocampal
neurons, but in opposition to findings at Drosophila
neuromuscular junction, where DCVs move antero- and
retrogradely at roughly the same speed (Shakiryanova et al.
2006; Barkus et al. 2008). Our findings are consistent with
speeds reported for motor proteins recruited for axonal
anterograde and retrograde movement, with kinesins
moving DCVs considerably faster than dynein (Maday
et al. 2014). The overall higher mean speed reported in
Fig. 6 compared with that reported in Fig. 4 might be
attributed to the fact that we only analysed axonal stretches
containing multiple moving DCVs, potentially interfering
with trafficking speed. Furthermore, overexpression of
MACF18-GFP might enhance microtubule growth rate
or stabilize microtubules. This could lead to elongation of
microtubule tracks and thus less pausing and higher mean
speeds. In conclusion, the anterograde trafficking speed of
DCVs is approximately 50% faster than retrograde trans-
port in vivo.
MACF18-GFP allowed us to monitor axonal micro-
tubule dynamics in the cerebral cortex in vivo. We found
a unidirectional polarity of axonal movement of micro-
tubules in vivo with a comet run length of around 10 μm.
In comparison to developing neurons, the number of
moving comets/unit of axon length is relatively small
(Conde & Cáceres, 2009). The mean speed of comet
growth was 0.12 μm/s, in agreement with findings of other
in vivo studies in spinal cord axons of 0.147 μm/s (Kleele
et al. 2014) and 0.09 μm/s in dendrites of cortical neurons
(Yau et al. 2016).
The newly discovered reduction in transport speed and
longer pausing times at axonal en-passant boutons may
be a mechanism to increase the availability of DCVs at
presynaptic sites (Wong et al. 2012), consistent with the
notion that these sites accumulate the protein complexes
that drive exocytosis and are the main locations of DCV
capture and release (Torrealba & Carrasco, 2004). The
mechanism that reduces DCV speed remains unclear.
Several mutually non-exclusive possibilities are plausible.
(1) Axonal en-passant boutons are small compartments
packed with proteins, mitochondria and synaptic vesicles.
Molecular (or organelle-) crowding could contribute
to slowing of DCV transport through these structures,
as indicated by diffusion models in boutons (Wragg
et al. 2015). (2) DCVs are mainly transported via
microtubule-mediated transport mechanisms (Barkus
et al. 2008). The slowing could be caused by shorter
microtubule tracks in and around boutons, causing more
frequent switches between tracks, in turn leading to an
effective slowing and more frequent directional changes.
(3) Microtubule-mediated transport is regulated through
post-translational modifications of tubulins (Schlager
et al. 2009), or motor proteins (Akhmanova & Hammer,
2010; Hirokawa et al. 2010). Synapses may accumulate
kinases and other modifying enzymes to specifically affect
trafficking speed at synapses. (4) DCVs are not only trans-
ported via microtubule-dependent motors, but also via
actin-dependent myosin motors (Bittins et al. 2010). The
presynaptic actin-myosin network may play a role in
tethering DCVs to the membrane and in DCV release
(Papadopulos et al. 2015). The highly local actin-myosin
motors may also contribute to the slowing of DCV trans-
port at presynaptic boutons. (5) Finally, fast axonal trans-
port of DCVs is known to be inhibited by activity in a
Ca2+-dependent manner (de Wit et al. 2006). Because
Ca2+-channels are known to accumulate in presynaptic
specializations, endogenous activity in the axons will pre-
ferentially increase intracellular free Ca2+ in boutons
and slow down DCV trafficking in this area. However,
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the slowing effect was also observed in anaesthetized
mice, presumed to have a lower neuronal activity. Taken
together, a number of possible mechanisms may explain
the slowing of DCVs in axonal boutons to increase their
availability at presynaptic sites.
References
Akhmanova A & Hammer JA (2010). Linking molecular
motors to membrane cargo. Curr Opin Cell Biol 22, 479–487.
Barkus R V, Klyachko O, Horiuchi D, Dickson BJ & Saxton
WM (2008). Identification of an axonal kinesin-3 motor for
fast anterograde vesicle transport that facilitates retrograde
transport of neuropeptides. Mol Biol Cell 19, 274–283.
Berbel P & Innocenti GM (1988). The development of the
corpus callosum in cats: a light- and electron-microscopic
study. J Comp Neurol 276, 132–156.
Bittins CM, Eichler TW, Hammer JA & Gerdes H-H (2010).
Dominant-negative myosin Va impairs retrograde but not
anterograde axonal transport of large dense core vesicles.
Cell Mol Neurobiol 30, 369–379.
Cohen S & Greenberg ME (2008). Communication between
the synapse and the nucleus in neuronal development,
plasticity, and disease. Annu Rev Cell Dev Biol 24, 183–209.
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Kim T, Gondré-Lewis MC, Arnaoutova I & Loh YP (2006).
Dense-core secretory granule biogenesis. Physiology
(Bethesda) 21, 124–133.
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Supporting Movie S1. DCVs trafficking through
thalamocortical axons imaged in an anaesthetized mouse
in vivo. Original frame rate: 1 Hz, sped up to 15 Hz. Movie
relates to Fig. 3.
Supporting Movie S2. DCVs trafficking through
thalamocortical axons imaged in an awake mouse in vivo.
Original frame rate: 1 Hz, sped up to 15 Hz. Movie relates
to Fig. 4.
Supporting Movie S3. Microtubule +-end extension
imaged in an anaesthetized mouse in vivo. Original frame
rate: 1 Hz, sped up to 10 Hz. Movie relates to Fig. 5.
Supporting Movie S4. Slowing of DCVs at presynaptic
boutons imaged in an anaesthetized mouse in vivo.
Original frame rate: 1 Hz, sped up to 15 Hz. Movie relates
to Fig. 7.
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